Summary - A new market study, titled “COVID-19 Diagnostics: Global Markets” has been featured on Report Scope:The current report offers a detailed picture of the market for COVID-19 diagnostics.COVID-19 is an infectious disease that is caused by the coronavirus and primarily affects the lungs.This report highlights the current and future market potential for COVID-19 diagnostics and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities and trends in the market.The report also covers market projections through 2027, as well as market shares for key market players.ALSO READ:https://www.medgadget.com/2020/09/global-covid-19-diagnostics-market-analysis-2020-trends-industry-growth-opportunities-forecast-to-2025.htmlThis report details market shares for COVID-19 diagnostics based on type, technology, end-user and geography.Based on technology, the market is segmented into reverse transcription polymerase chain reaction (RT-PCR), isothermal amplification, clustered regularly interspaced short palindromic repeats (CRISPR), enzyme-linked immunosorbent assay (ELISA), hybridization and others.By geography, the market has been segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.Detailed analyses of major countries (the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India) are covered in regional segments.Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.Report Includes:- 56 data tables and 39 additional tables- An overview of the global market for COVID-19 diagnostics- Estimation of the market size of global COVID-19 diagnostics and analyses of global market trends, with estimated data from 2020, 2021 and projections of compound annual growth rates (CAGRs) through 2027- Explanation of factors driving and restraining the growth of global COVID-19 diagnostics market- A look at the Case-Fatality Rate (CFR), global confirmed cases and confirmed deaths due to COVID-19 and COVID-19 clinical trial landscape- Information on potential targets for COVID-19 drug development such as Basigin (CD147), C-C Chemokine Receptor Type 5 (CCR5) and many more- Details about collaboration between organizations and governments to stop this pandemic and recent research and development activities for COVID-19- Market share analysis of the key companies of the industry, their strategic profiling and key competitive landscape- Detailed company profiles of market leading participants, including Abbott, Danaher Corp., Bio-Rad Laboratories Inc., F. Hoffman-La Roche Ltd., and Thermo Fisher Scientific Inc.Summary:The global market for COVID-19 diagnostics was valued at REDACTED in 2020.
When you think of Mercedes C-Class the first thing which comes to mind is a well-engineered German car.With this in mind most people would never think of tuning a Mercedes for better performance as they are able to hold their own against their competitors.The ECU is the computer system which monitors and manages the engine.However, a major drawback to performing an ECU remap is that you would have to service your car more regularly.Lighter Flywheel – a heavy flywheel means that it is more difficult for the engine to accelerate or decelerate.The advantage of a heavy flywheel is only visible on long journeys.If you drive around the city a lot then you will definitely feel the power gain from replacing your flywheel with a lighter one.
The global waste to energy market is extremely competitive.These companies are focused on bring in better technology to strengthen the process of waste to energy, says Transparency Market Research (TMR) report.Some of the key players in the global waste to energy market are –Suez Environment S.A., Covanta, Waste Management, Inc., China Everbright International Limited, and C& G Environmental Protection Holdings.The demand for converting solid waste to energy has been rising keeping environmental factor and alternative energy source as an objective.Advanced technology and safe process of converting municipal waste into renewable energy drives the global waste to energy market.The global waste to energy market is predicted to grow at a steady rate in upcoming years.Regionally, Europe dominated the global waste to energy market previously and is likely to continue its dominance in coming years.Thermochemical technology segment is likely to dominate the global market during the forecast period.Request A Sample – https://www.transparencymarketresearch.com/sample/sample.php?flag=S_id=10442Increasing Waste to Promote MarketWaste is increasing across the globe in the form of solid waste, municipal waste, and agricultural waste.Converting these waste into renewable energy to overcome the environmental issues such as increasing landfills.
Cathepsin B - Pipeline Review, H2 2020Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/cathepsin-b-pipeline-review-h-2020-780SummaryCathepsin B (APP Secretase or Cathepsin B1 or CTSB or EC 126.96.36.199) pipeline Target constitutes close to 8 molecules.Out of which approximately 6 molecules are developed by companies and remaining by the universities/institutes.The latest report Cathepsin B - Pipeline Review, H2 2020, outlays comprehensive information on the Cathepsin B (APP Secretase or Cathepsin B1 or CTSB or EC 188.8.131.52) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type.Cathepsin B (APP Secretase or Cathepsin B1 or CTSB or EC 184.108.40.206) - Cathepsin B (CatB) is an enzymatic protein belonging to the peptidase.It promotes hydrolysis of proteins with broad specificity for peptide bonds.It cleaves -Arg-Arg-|-Xaa bonds in small molecule substrates.In addition to being an endopeptidase, shows peptidyl-dipeptidase activity, liberating C-terminal dipeptides.
The global long term care market size is expected to reach USD 1.7 billion by 2026, exhibiting a 7.5% CAGR during the forecast period.In addition to this, increasing awareness about different long term care (LTC) facilities and the increasing medical coverage for home healthcare are likely to benefit market growth.Access Sample Report of this report @ https://www.radiantinsights.com/research/long-term-care-market/request-sampleAccording to data published by the United Nations in 2017, it has been estimated that the number of people above 60 of years of age is expected to double between 2017 and 2050.The number of nursing facilities has reduced over the past several years, while the prevalence of in-home nursing programs have doubled.Developing economies make for lucrative markers as far as home healthcare is concerned.India, for instance, has many home healthcare startups such as Health Care at Home, Zoctr, Vatsalya, Zozz, Life Circle Health Services, Healers at Home, and the Nightingales, a factor that has worked in its favor.In November 2017, Portea raised USD 26.0 million in the Series C funding for better home healthcare facilities.Growing medical coverage by government and private insurers has had a positive impact on market growth.According to the Hospice Association of America, Medicare pays USD 173 per day for inpatient respite care, USD 744 per day for general inpatient care, USD 193 per day for routine homecare, and USD 41 per hour for continuous homecare.
Phenom, the global leader in Talent Experience Management (TXM), today announced its inclusion on Deloitte’s 2020 Technology Fast 500™, a list of the 500 fastest-growing technology, media, telecommunications, life sciences and energy tech companies in North America.Phenom demonstrated the most rapid growth among Pennsylvania tech companies for the second year in a row — over 50% higher than the full list’s median growth rate.Phenom is also adding to its rapidly growing team, as employees now number over 800.Despite this year’s economic uncertainty, Phenom has marked several milestones that continue to fuel the company’s growth, including:A $30 million Series C funding roundThe launch of HelpOneBillion — Phenom’s curated job network with over 875,000 openings — in response to the COVID-19 pandemicThe development of several new product innovations for the TXM platform, including True 1-to-1 Personalization, Phenom Gigs, Frontline Hiring Manager and Phenom SchedulingThe acquisition of My Ally and its advanced automation technologyA collaboration with Microsoft Teams, enabling the integration of Phenom’s API into one of today’s most widely used communication platforms“We want to highlight our customers and partners, whose loyalty and collaboration inspire us to never stop innovating,” said Mahe Bayireddi, co-founder and CEO of Phenom.“It’s so rewarding to see our technology help companies and candidates find the right fit, while also fostering the professional development of talented employees.Phenom is a global company, and we’ll continue to refine our technology so talent acquisition and talent management professionals always have a competitive edge.”Overall, 2020 Technology Fast 500™ companies achieved revenue growth ranging from 175% to 106,508% from 2016 to 2019, with median growth of 450%.“Each year the Technology Fast 500 listing validates how important technology innovation is to our daily lives.It was interesting to see this year that while software companies continued to dominate, biotech companies rose to the top of the winners list for the first time, demonstrating that new categories of innovation are accelerating in the pursuit of making life easier, safer and more productive,” said Mohana Dissanayake, partner, Deloitte & Touche LLP, and industry leader for technology, media and telecommunications, within Deloitte’s audit and assurance practice.
ACS Group (Spain), Skanska AB (Sweden), Komatsu Ltd (Japan), L (India), Balfour Beatty Plc.(U.K.), Kiewit Corporation (U.S.), Taisei Corporation (Japan), Red Sea Housing Services (Saudi Arabia), System House R & C Co. Ltd (Japan), and Bouygues Construction (France) are some of the prominent players profiled in MRFR Analysis and are at the forefront of the competition in the Global Modular Construction Market.Modular Construction Global MarketModular Construction also known as pre-fabricated/prefab and pre-factored building or sometimes also referred as offsite construction is a booming trend in the construction industry worldwide.Attributing to the range of advantages it offers in comparison with the traditional methods; modular construction is widely used in healthcare sector, public & private sector buildings, hotels, housing, apartment, educational sector, hostels and so on.Student accommodation/ hostels, military accommodation and hotels segments account for the largest users of Modular Construction.However the healthcare sector is the significant one owing to the perceptive requirement like highly complex services and medical installations to be tested and commissioned off-site.Get Free Sample Report : https://www.marketresearchfuture.com/sample_request/1682Some of the key benefits of Modular Construction include cost effective, speedy onsite installation, quality products owing to the high level of quality control maintained in factory production, light weight hence easy to transport/relocate, Suitable for small size/ compacted sites where working space is a constraint.Additionally, high level of acoustic separation that provides sound attenuation.
Cathepsin B - Pipeline Review, H2 2020Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/cathepsin-b-pipeline-review-h-2020-780Cathepsin B - Pipeline Review, H2 2020Cathepsin B (APP Secretase or Cathepsin B1 or CTSB or EC 220.127.116.11) pipeline Target constitutes close to 8 molecules.Out of which approximately 6 molecules are developed by companies and remaining by the universities/institutes.The latest report Cathepsin B - Pipeline Review, H2 2020, outlays comprehensive information on the Cathepsin B (APP Secretase or Cathepsin B1 or CTSB or EC 18.104.22.168) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type.Cathepsin B (APP Secretase or Cathepsin B1 or CTSB or EC 22.214.171.124) - Cathepsin B (CatB) is an enzymatic protein belonging to the peptidase.It promotes hydrolysis of proteins with broad specificity for peptide bonds.It cleaves -Arg-Arg-|-Xaa bonds in small molecule substrates.In addition to being an endopeptidase, shows peptidyl-dipeptidase activity, liberating C-terminal dipeptides.
SummaryA new market study, titled “Global UV-C Disinfection Robot Market Size study, by Type (Portable Type, Stationary Type), by Application (Hospital & Clinics, Biosafety Laboratory, Drug Production Workshop, Others) and Regional Forecasts 2020-2027” has been featured on WiseGuyReports.The UV-C disinfection robots are a type of robotic systems that make use of ultraviolet radiation to exterminate the germs.The robots developed with UV-C light, are used as a part of the consistent cleaning cycle, which results in preventing and reducing the spread of communicable diseases caused by viruses, bacteria, and other types of damaging organic microorganisms in the atmosphere.Moreover, the recent outbreak of the COVID-19 throughout the world has insisted on various regional governments to adopt health & safety measures as well as medical robots.For instance: According to the World Health Organization (WHO), as of 6th July 2020, the global number of COVID-19 cases was estimated at around 11.3 million with 532,340 deaths, demonstrating an increase from around 1 million on 4th April 2020 with 59,285 deaths.However, the high cost of UV-C disinfection robots is one of the major factors impeding the market growth over the forecast period of 2020-2027.ALSO READ: https://www.openpr.com/news/2137490/global-uv-c-disinfection-robot-market-industry-analysis-sizeThe regional analysis of the global UV-C Disinfection Robot market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World.
Identification of contemporary market trends, depicted using five schematic representations, which include [A] a tree map representation of the various industry players involved in the development of stem cell therapies, distributed on the basis of the target therapeutic areas of pipeline candidates and size of the companies (small, mid-sized and large companies), [B] a schematic world map representation, highlighting the geographical locations of various industry players, [C] a bubble analysis comparing the leading players engaged in the generation of stem cell therapies, on the basis of parameters such as pipeline strength (based on the number of therapy candidates developed by a particular company, across different phases of development), number of target indications and the size of the developer company, [D] an insightful grid analysis, highlighting the distribution of therapy candidates on the basis of phase of development, source of stem cell and target therapeutic areas, and [E] an informative heptagon representation, highlighting the distribution of marketed / clinical stem cell therapies across popular target therapeutic areas (based on the number of therapy candidates across each target therapeutic areas).Detailed profiles of the key industry players engaged in the development of stem cell-based therapies, featuring a brief overview of the company (such as year of establishment, company size, location of headquarters, key members of the executive team and financial information (if available)), details of their respective product portfolio and an informed future outlook.An assessment of over 20 commonly targeted therapeutic indications and details of stem cell-based therapies being developed to treat the same conditions, highlighting disease specific epidemiological facts, contemporary methods of diagnosis, and currently available treatment options and their side-effects.A detailed proprietary 2×2 representation that was developed to assess the current market scenario (in terms of existing competition and growth opportunities) across emerging and established market segments.An in-depth analysis of more than 1,500 grants that have been awarded to research institutes engaged in stem cell therapy-related projects, in the period between 2015 and 2019 (till November), including analysis based on important parameters, such as year of grant award, amount awarded, administration institute, funding institute center, funding institute center, support period, spending categorization, funding mechanism, grant type, responsible study section, focus area, prominent program officers, and type of recipient organizations.A detailed clinical trial analysis on more than 540 completed, ongoing and planned studies of various stem cell therapies, highlighting prevalent trends across various relevant parameters, such as current trial status, trial registration year, phase of development, study design, leading industry sponsors (in terms of number of trials conducted), study focus, type of stem cells, target indication(s), target therapeutic area(s), enrolled patient population and regional distribution of trials.
With multiple approved products, the field of stem cell therapies has gained substantial momentum over the last decade; several innovator companies are currently progressing their proprietary therapy candidates with cautious optimism.In fact, recent studies suggest that mesenchymal stem cells have the potential to end the Coronavirus (COVID-19) pandemic.Roots Analysis is pleased to announce the publication of its recent study, titled, “Global Stem Cells Market: Focus on Clinical Therapies, 2020–2030 (Based on Source (Allogeneic, Autologous); Origin (Adult, Embryonic); Type (Hematopoietic, Mesenchymal, Progenitor); Lineage (Amniotic Fluid, Adipose Tissue, Bone Marrow, Cardiosphere, Chondrocytes, Corneal Tissue, Cord Blood, Dental Pulp, Neural Tissue Placenta, Peripheral Blood, Stromal Cells); and Potency (Multipotent, Pluripotent))”.The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics over the next decade.In addition to other elements, the study includes:A detailed assessment of the current market landscape of companies engaged in the development of stem cell therapies for treatment of wide range of clinical conditionsElaborate profiles of key industry players engaged in the development of stem cell therapies (shortlisted on the basis of the product portfolio).An insightful competitiveness analysis featuring a four-dimensional bubble chart, highlighting the key players in this domain.An assessment of over 20 commonly targeted therapeutic areas and details of stem cell-based therapies being developed to treat the same conditions.A detailed proprietary 2×2 representation that was developed to assess the current market scenario (in terms of existing competition and growth opportunities) across emerging and established market segments.An in-depth analysis of more than 1,500 grants that have been awarded to research institutes engaged in stem cell therapy-related projects, in the period between 2015 and 2019 (till November)A detailed clinical trial analysis on more than 540 completed, ongoing and planned studies of various stem cell therapies, highlighting prevalent trends across various relevant parameters.A review of the key aspects related to the manufacturing of stem cell therapies, including [A] a detailed discussion on processes and protocols, highlighting the need to outsource various aspects of stem cell therapy development and manufacturing operations, [B] an assessment of the current market landscape of contract manufacturers, providing information on stem cell-focused service providers, and [C] an insightful Harvey ball analysis to identify the key performance indicators / key considerations that industry stakeholders are likely to take into consideration while selecting a suitable CMO / CRO partner.A detailed market gap analysis in order to develop a realistic understanding of the demand and supply dynamics within this field, comparing both clinical and commercial capabilities of therapy developers and the availability and capabilities of contract manufacturers, across different geographies.An elaborate discussion on the various strategies that can be adopted by stem cell therapy developers across different stages of product development and commercialization.A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)Source of Stem CellAllogeneicAutologous Origin of Stem CellAdultEmbryonic Type of Stem CellHematopoieticMesenchymalProgenitorOthers Lineage of Stem CellAdipose TissueBone MarrowCord BloodOthers Route of AdministrationIntraarticularIntracoronaryIntramuscularIntramyocardialIntrathecalIntravenousSurgical ImplantationsOthers Therapeutic AreaAutoimmune / Inflammatory DisorderCardiovascular DisordersMetabolic DisorderMusculoskeletal DisordersOncological DisordersNeurological DisordersOphthalmic DisordersOthers End UsersAmbulatory Surgery CentersHospitalsSpecialty Clinics Key Geographical RegionsNorth AmericaEuropeAsia-Pacific and Rest of the World Transcripts of interviews held with the following senior level representatives of stakeholder companiesWilliam L Rust (Founder and Chief Executive Officer, Seraxis)Xuejun Huang Parsons (Chief Executive Officer, Xcelthera)Michel Revel (Co-Founder and Chief Scientist, Kadimastem) and Galit Mazooz-Perlmuter (Director, Business Development, Kadimastem)Kikuo Yasui (Director and Chief Operating Officer, Heartseed)Gustav Steinhoff (Director and Chairman, Department of Cardiac Surgery, University of Rostock)Gilles Devillers (President, Bio Elpida)Fiona Bellot (Business Development Manager, Roslin Cell Therapies)David Mckenna (Professor and American Red Cross Chair in Transfusion Medicine, University of Minnesota)Brian Dattilo (Manager of Business Development, Waisman Biomanufacturing)Mathilde Girard (Department Leader, Cell Therapy Innovation and Development, YposKesi) Key companies covered in the reportAnterogenAthersysCHABiotechCytopeuticsHope BiosciencesJapan Regenerative MedicineLineage Cell TherapeuticsOrchard TherapeuticsOsiris TherapeuticsPluristem TherapeuticsPromithera BiosciencesRegenexxStempeutics ResearchSCM Life SciencesTICEBA For more information please click on the following link:https://www.rootsanalysis.com/reports/view_document/stem-cells-market/296.html/ Other Recent OfferingsStem Cell Therapy Contract Manufacturing Market, 2019-2030Antibody Drug Conjugates Market (5th Edition), 2019-2030Cell and Advanced Therapies Supply Chain Management Market, 2019-2030: Focus on Technological SolutionsGlobal T-Cell (CAR-T, TCR, and TIL) Therapy Market (4th Edition), 2019 – 2030 About Roots AnalysisRoots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry.The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector.
The global Hemostats market was valued at $XX million in 2017, and Radiant Insights, Inc. analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2017 and 2028.This report provides detailed historical analysis of global market for Hemostats from 2013-2018, and provides extensive market forecasts from 2018-2028 by region/country and subsectors.Download Free Sample Report @ https://www.radiantinsights.com/research/2013-2028-report-on-global-hemostats-market/request-sample Leading players of Hemostats including:• Ethicon• Pfizer• Baxter International Inc.• C. R. Bard• The Medicines Company• Anika Therapeutics, Inc.• Advanced Medical Solutions• Integra LifeSciences Corporation• B Braun Melsungen AG• Gelita Medical GmbH• Equimedical• Vascular Solutions, Inc.• Marine Polymer Technologies, Inc.• Z-Medica, LLC• CryoLife, Inc.• BioCer Entwicklungs-GmbH• Biom'Up SAS Market split by Type, can be divided into:• Hydrocolloid Sponges• Gelatin Sponges• Hemostat Powder• Others Market split by Application, can be divided into:• Ophthalmic• Urology• Orthopedics• Capillary Hemorrhage• Venous Hemorrhage• Arterial Hemorrhage Market split by Sales Channel, can be divided into:• Direct Channel• Distribution Channel Market segment by Region/Country including:• North America (United States, Canada and Mexico)• Europe (Germany, UK, France, Italy, Russia and Spain etc.)• Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)• Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)Browse Full Research Report with TOC @ https://www.radiantinsights.com/research/2013-2028-report-on-global-hemostats-market Table of Contents Chapter 1 Hemostats Market Overview1.1 Hemostats Definition1.2 Global Hemostats Market Size Status and Outlook (2013-2028)1.3 Global Hemostats Market Size Comparison by Region (2013-2028)1.4 Global Hemostats Market Size Comparison by Type (2013-2028)1.5 Global Hemostats Market Size Comparison by Application (2013-2028)1.6 Global Hemostats Market Size Comparison by Sales Channel (2013-2028)1.7 Hemostats Market Dynamics1.7.1 Market Drivers/Opportunities1.7.2 Market Challenges/Risks1.7.3 Market News (Mergers/Acquisitions/ Expansion) Chapter 2 Hemostats Market Segment Analysis by Player2.1 Global Hemostats Sales and Market Share by Player (2016-2018)2.2 Global Hemostats Revenue and Market Share by Player (2016-2018)2.3 Global Hemostats Average Price by Player (2016-2018)2.4 Players Competition Situation & Trends2.5 Conclusion of Segment by Player Chapter 3 Hemostats Market Segment Analysis by Type3.1 Global Hemostats Market by Type3.1.1 Hydrocolloid Sponges3.1.2 Gelatin Sponges3.1.3 Hemostat Powder3.1.4 Others3.2 Global Hemostats Sales and Market Share by Type (2013-2018)3.3 Global Hemostats Revenue and Market Share by Type (2013-2018)3.4 Global Hemostats Average Price by Type (2013-2018)3.5 Leading Players of Hemostats by Type in 20173.6 Conclusion of Segment by Type Continued… Read all Reports of this category @ https://www.radiantinsights.com/catalog/medical-devices About Radiant InsightsRadiant Insights is a platform for companies looking to meet their market research and business intelligence requirements.
Summary - A new market study, titled “Global Eco-Friendly Tiles Market Insights and Forecast to 2026” has been featured on WiseGuyReports.Eco-Friendly Tiles market is segmented by Type, and by Application.The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.Segment by Type, the Eco-Friendly Tiles market is segmented intoCeramicTravertinePorcelainTerrazzoGlass Also Read: https://industrytoday.co.uk/health_and_safety/organic-sanitary-napkins-market-players-analysis--procter---gamble--unicharm--kao--kimberly-clark--c-bons--bodywise---the-honest-company--corman--maxim--natratouch Segment by Application, the Eco-Friendly Tiles market is segmented intoResidentialNon-residential Regional and Country-level AnalysisThe Eco-Friendly Tiles market is analysed and market size information is provided by regions (countries).The key regions covered in the Eco-Friendly Tiles market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa.It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.The report includes country-wise and region-wise market size for the period 2015-2026.It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.Competitive Landscape and Eco-Friendly Tiles Market Share AnalysisEco-Friendly Tiles market competitive landscape provides details and data information by players.
Bachelor of Science | PreparatoryDoctor of Medicine at Yale University School of Medicine | Valmont UniversityAdmissions office work experience:• University of Pennsylvania Admissions OfficeConsultant Expertise:• Liberal Arts College/Medical School Preparatory Course Application and Advancement Planning• K-12 Private School Admissions GuidanceClick here : https://miro.medium.com/fit/c/1360/1360/1*PICdNUWDlO0QkPi2fjBVdw.jpeg
(علت سر و صدای یخچال)نمایش ارورهایی چون F1 C ،1 و یا F10 g بر روی نمایشگر یخچال (بررسی انواع ارور یخچال سامسونگ)مراحل گام به گام تعمیر برد یخچال سامسونگبرای تعمیر و بررسی برد الکترونیکی یخچال سامسونگ، بهتر است که مراحل زیر را دنبال نمایید:قیمت برد یخچال سامسونگ۱- برق یخچال را به صورت کامل قطع کنید.برای تعمیر برد، نیاز هست که یخچال فریزر را از برق جدا کنید و به سمت جلوتر هل دهید تا از دیوار فاصله بیشتری بگیرد.